Attention-deficit/hyperactivity Disorder Among Chronic Methamphetamine Users: Frequency, Persistence, and Adverse Effects on Everyday Functioning

Overview

Journal Addict Behav

Specialties Psychiatry
Social Sciences

Date 2013 Sep 11

PMID 24018233

Citations 12

Authors

Lisa C Obermeit

Jordan E Cattie

Khalima A Bolden

Maria J Marquine

Erin E Morgan

Donald R Franklin Jr

J Hampton Atkinson

Igor Grant

Steven Paul Woods

Affiliations

Soon will be listed here.

Abstract

Aims: Attention-Deficit/Hyperactivity Disorder (ADHD) is widely regarded as a common comorbidity of methamphetamine (MA) dependence, but the frequency, persistence, and real-world impact of ADHD among MA users are not known.

Methods: Four hundred individuals with MA use disorders within 18months of evaluation and 355 non-MA using comparison subjects completed a comprehensive neuropsychiatric research battery, including self-report measures of everyday functioning.

Results: In logistic regression models adjusting for potential confounds, lifetime diagnoses of ADHD as determined by a structured clinical interview were significantly more prevalent among the MA participants (21%) versus comparison subjects (6%), particularly the hyperactive and combined subtypes. MA use was also associated with an increased persistence of combined subtype of ADHD into adulthood. Among the MA users, lifetime ADHD diagnoses were uniquely associated with greater concurrent risk of declines in instrumental activities of daily living, elevated cognitive symptoms in day-to-day life, and unemployment.

Conclusions: Findings indicate that ADHD is prevalent among chronic MA users, who are at increased risk for persistence of childhood diagnoses of ADHD into their adult years. ADHD also appears to play an important role in MA-associated disability, indicating that targeted ADHD screening and treatment may help to improve real-world outcomes for individuals with MA use disorders.

Citing Articles

Protective effect of melatonin against methamphetamine-induced attention deficits through miR-181/SIRT1 axis in the prefrontal cortex.

Rashidi S, Dezfouli M, Khodagholi F, Dadashpour M, Shabani A Mol Biol Rep. 2024; 51(1):690.

PMID: 38796575 DOI: 10.1007/s11033-024-09631-1.

Attention-deficit/hyperactivity disorder combined subtype exacerbates opioid use disorder consequences: Mediation by impulsive phenotypes.

Browning L, Cannoy C, Moses T, Lundahl L, Ledgerwood D, Greenwald M Drug Alcohol Depend. 2024; 259:111292.

PMID: 38640865 PMC: 11111336. DOI: 10.1016/j.drugalcdep.2024.111292.

The Use of Lisdexamfetamine to Treat ADHD in a Patient with Stimulant (Methamphetamine) Use Disorder.

Levine J, Swanson H Case Rep Psychiatry. 2023; 2023:5574677.

PMID: 37609571 PMC: 10442178. DOI: 10.1155/2023/5574677.

Identification and treatment of individuals with attention-deficit/hyperactivity disorder and substance use disorder: An expert consensus statement.

Young S, Abbasian C, Al-Attar Z, Branney P, Colley B, Cortese S World J Psychiatry. 2023; 13(3):84-112.

PMID: 37033892 PMC: 10075023. DOI: 10.5498/wjp.v13.i3.84.

The motivation against change in male methamphetamine users in the compulsory detoxification setting.

Shen W, Li L, Liu Y, Xie X, Chen W, Liu H Front Psychiatry. 2023; 14:1022926.

PMID: 36815195 PMC: 9939637. DOI: 10.3389/fpsyt.2023.1022926.

References

Hser Y, Evans E, Huang Y . Treatment outcomes among women and men methamphetamine abusers in California. J Subst Abuse Treat. 2005; 28(1):77-85. DOI: 10.1016/j.jsat.2004.10.009. View

Biederman J, Mick E, Faraone S, Braaten E, Doyle A, Spencer T . Influence of gender on attention deficit hyperactivity disorder in children referred to a psychiatric clinic. Am J Psychiatry. 2002; 159(1):36-42. DOI: 10.1176/appi.ajp.159.1.36. View

Heaton R, Marcotte T, Rivera Mindt M, Sadek J, Moore D, Bentley H . The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc. 2004; 10(3):317-31. DOI: 10.1017/S1355617704102130. View

Arnsten A . Stimulants: Therapeutic actions in ADHD. Neuropsychopharmacology. 2006; 31(11):2376-83. DOI: 10.1038/sj.npp.1301164. View

Lawton M, Brody E . Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969; 9(3):179-86. View

Disney E, Elkins I, McGue M, Iacono W . Effects of ADHD, conduct disorder, and gender on substance use and abuse in adolescence. Am J Psychiatry. 1999; 156(10):1515-21. DOI: 10.1176/ajp.156.10.1515. View

Jaffe C, Bush K, Straits-Troster K, Meredith C, Romwall L, Rosenbaum G . A comparison of methamphetamine-dependent inpatients childhood attention deficit hyperactivity disorder symptomatology. J Addict Dis. 2005; 24(3):133-52. DOI: 10.1300/J069v24n03_11. View

Wilens T, Faraone S, Biederman J, Gunawardene S . Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics. 2003; 111(1):179-85. DOI: 10.1542/peds.111.1.179. View

Moore D, Blackstone K, Woods S, Ellis R, Atkinson J, Heaton R . Methamphetamine use and neuropsychiatric factors are associated with antiretroviral non-adherence. AIDS Care. 2012; 24(12):1504-13. PMC: 3466384. DOI: 10.1080/09540121.2012.672718. View

10.

Horner B, SCHEIBE K . Prevalence and implications of attention-deficit hyperactivity disorder among adolescents in treatment for substance abuse. J Am Acad Child Adolesc Psychiatry. 1997; 36(1):30-6. DOI: 10.1097/00004583-199701000-00014. View

11.

de Graaf R, Kessler R, Fayyad J, Have M, Alonso J, Angermeyer M . The prevalence and effects of adult attention-deficit/hyperactivity disorder (ADHD) on the performance of workers: results from the WHO World Mental Health Survey Initiative. Occup Environ Med. 2008; 65(12):835-42. PMC: 2665789. DOI: 10.1136/oem.2007.038448. View

12.

Blackstone K, Iudicello J, Morgan E, Weber E, Moore D, Franklin D . Human immunodeficiency virus infection heightens concurrent risk of functional dependence in persons with long-term methamphetamine use. J Addict Med. 2013; 7(4):255-63. PMC: 3737384. DOI: 10.1097/ADM.0b013e318293653d. View

13.

Faraone S, Wilens T, Petty C, Antshel K, Spencer T, Biederman J . Substance use among ADHD adults: implications of late onset and subthreshold diagnoses. Am J Addict. 2007; 16 Suppl 1:24-32. DOI: 10.1080/10550490601082767. View

14.

Blackstone K, Tobin A, Posada C, Gouaux B, Grant I, Moore D . HIV-infected persons with bipolar disorder are less aware of memory deficits than HIV-infected persons without bipolar disorder. J Clin Exp Neuropsychol. 2012; 34(7):773-81. PMC: 3718038. DOI: 10.1080/13803395.2012.682974. View

15.

Weber E, Blackstone K, Iudicello J, Morgan E, Grant I, Moore D . Neurocognitive deficits are associated with unemployment in chronic methamphetamine users. Drug Alcohol Depend. 2012; 125(1-2):146-53. PMC: 3735422. DOI: 10.1016/j.drugalcdep.2012.04.002. View

16.

Scott J, Woods S, Matt G, Meyer R, Heaton R, Atkinson J . Neurocognitive effects of methamphetamine: a critical review and meta-analysis. Neuropsychol Rev. 2007; 17(3):275-97. DOI: 10.1007/s11065-007-9031-0. View

17.

Sonuga-Barke E, Fairchild G . Neuroeconomics of attention-deficit/hyperactivity disorder: differential influences of medial, dorsal, and ventral prefrontal brain networks on suboptimal decision making?. Biol Psychiatry. 2012; 72(2):126-33. DOI: 10.1016/j.biopsych.2012.04.004. View

18.

Rippeth J, Heaton R, Carey C, Marcotte T, Moore D, Gonzalez R . Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. J Int Neuropsychol Soc. 2004; 10(1):1-14. DOI: 10.1017/S1355617704101021. View

19.

Henry B, Minassian A, Perry W . Effect of methamphetamine dependence on everyday functional ability. Addict Behav. 2010; 35(6):593-8. PMC: 2839012. DOI: 10.1016/j.addbeh.2010.01.013. View

20.

Paulus M, Tapert S, Schuckit M . Neural activation patterns of methamphetamine-dependent subjects during decision making predict relapse. Arch Gen Psychiatry. 2005; 62(7):761-8. DOI: 10.1001/archpsyc.62.7.761. View